imaradenant



imaradenant


SMILES Cc1cc(-c2nnc(N)nc2-c2ccc(F)cc2)cc(Cl)n1
InChIKey NCWQLHHDGDXIJN-UHFFFAOYSA-N

Chemical Properties

Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 2
Molecular weight (Da) 315.1

Database connections

Structure pdb 6GT3
Ligand site mutations A2A

Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

imaradenant


Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Structure pdb 6GT3
Ligand site mutations A2A

Compound is not listed as a drug.